Indinavir is a protease inhibitor used as a component of highly active antiretroviral therapy to treat HIV/AIDS.
Indinavir
Indinavir; Crixivan; Compound J; MK-639
Inbec, Inbed, Ind, Indease, Indivan, Indivir, Virodin
(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide
Oral absorption.
Indinavir inhibits the HIV viral protease enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.
The recommended dose is 800 mg 8 hourly orally.
Indinavir is an antiretroviral drug prescribed for the treatment of HIV infection.
Flank pain, abdominal pain, nephrolithiasis, malaise, nausea, vomiting, diarrhoea, elevated liver enzymes, hyperbilirubinaemia, raised creatinine phosphokinase and blood lipids, back pain, lipodystrophy, alopecia, acid regurgitation, dyspepsia, dry mouth, dysuria, dry skin, hyperpigmentation, headache, dizziness, somnolence, cough, dyspnoea.
Hypersensitivity. Severe hepatic impairment.
Store at 15-30°C
613.7895
C36H47N5O4
150378-17-9